#TumorTalk is back today at 4p EST! - We’re diving into a provocative question in glioblastoma care: do antidepressants with anti-acid sphingomyelinase activity have any measurable impact on survival? - Join Erik Sulman, MD, PhD, and Luiz Henrique Medeiros Geraldo, MD, PhD, as they break down their retrospective analysis, explore the biologic rationale behind these agents, and discuss what this signal may—or may not—mean for patients with glioblastoma. - Hosted by seattlesciencefoundation and jneurooncol - 🔗 Link in bio! — #braintumor #glioblastoma #gbm #neurooncology TumorTalk braincancer translationalresearch oncologyresearch